Dr. Reddy's Laboratories Ltd Common Stock (RDY)

Stockholders Equity

₹383.43B

Quarterly · Period ending: · INR

RDY logo

RDY Stockholders Equity

Latest reported₹383.43B INR
RDY Quarterly Shareholders Equity · INR (₹11.53B → ₹383.43B)
High-resolution chart · PNG

RDY stockholders equity history

Quarterly · INR. Dates are reporting period ends; fiscal years can differ from calendar years.

Dr. Reddy's Laboratories Ltd Common Stock Stockholders Equity — Quarterly (INR)
Period endingStockholders Equity (INR)
383,428,000,000
369,598,167,000
372,366,000,000
358,489,000,000
350,059,000,000
333,388,000,000
317,721,000,000
305,344,000,000
294,627,000,000
280,550,000,000
3,218,819,005
253,086,000,000
245,260,000,000
230,991,000,000
2,662,552,882
2,534,994,852
2,537,452,910
2,514,378,093
2,556,189,392
2,477,895,658
2,396,259,921
2,367,023,986
2,318,335,785
2,240,946,055
2,142,251,212
2,048,716,974
2,082,878,303
153,816,000,000
146,208,000,000
140,197,000,000
135,708,000,000
131,446,000,000
130,430,000,000
126,460,000,000
123,685,000,000
121,840,000,000
123,423,000,000
124,044,000,000
121,040,000,000
115,264,000,000
114,112,000,000
128,336,000,000
128,681,000,000
121,499,000,000
118,885,000,000
111,302,000,000
105,107,000,000
99,004,000,000
96,730,000,000
90,801,000,000
85,168,000,000
78,069,000,000
75,035,000,000
730,853,000,000
66,789,000,000
63,205,000,000
59,664,000,000
57,444,000,000
51,926,000,000
48,081,000,000
48,902,000,000
45,990,000,000
48,151,000,000
45,245,000,000
44,966,000,000
42,915,000,000
40,533,000,000
45,648,000,000
44,832,000,000
42,045,000,000
51,850,000,000
49,693,774,000
49,294,929,000
47,066,600,000
44,967,843,618
45,272,805,611
43,175,179,212
41,676,758,840
38,552,492,881
26,415,857,879
24,088,500,192
22,329,294,071
22,474,446,826
21,826,951,714
21,335,782,181
20,953,143,015
19,785,303,952
21,377,247,877
21,223,815,402
21,084,990,155
20,821,141,344
20,224,942,619
19,745,907,865
18,777,727,127
18,220,623,237
17,482,609,150
16,712,734,624
15,440,468,747
14,444,337,024
13,480,289,348
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.